ArticleBMC surgery2026
Surgical treatment outcomes of elastofibroma dorsi in 16 patients with 22 lesions.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElastofibroma dorsi is a rare, slow-growing, benign soft tissue tumor typically located under the scapula. Although elastofibroma dorsi is a benign lesion, it may cause symptoms such as pain and restriction of movement, and its mass-like appearance can lead to considerable patient anxiety. We aimed to present patients diagnosed with elastofibroma dorsi who had clinical complaints and underwent surgical treatment, in conjunction with the literature in this study.
methodsOur study retrospectively analyzed lesions surgically treated in the Orthopedics and Traumatology and Thoracic Surgery Clinics over the past five years, which were pathologically confirmed as elastofibroma dorsi. All patients were operated on in the prone position under general anesthesia, and all excised lesions underwent postoperative pathological examination.
resultsA total of 22 elastofibroma dorsi lesions were identified in 16 patients, including 6 patients with bilateral involvement. The mean age of the patients was 62.3 years (range, 46–76). Of these lesions, 13 (59.1%) were located on the right side and 9 (40.9%) on the left. The predominant presenting symptoms were pain, limitation of shoulder motion, cosmetic concerns, and the presence of a palpable mass. Lesion sizes ranged from 5 to 10 cm in diameter. Magnetic resonance imaging or computed tomography consistently demonstrated well-defined tumors situated posterolaterally in the chest wall, between the serratus anterior and latissimus dorsi muscles. All patients underwent marginal resection following anatomical dissection of the involved muscle groups. Postoperatively, seromas developed in 8 lesions (36.4%) and a hematoma in 1 lesion (4.5%). The seromas were successfully managed with aspiration and compression bandaging, while the hematoma required surgical reintervention.
conclusionsElastofibroma dorsi is a slowly growing benign lesion typically located beneath the inferior scapula. In symptomatic patients, surgical excision results in a marked improvement of symptoms. The most common surgical complication is the development of postoperative seroma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.